Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-21-060230

Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Crystal Adam Chief Medical Officer 2021-10-08 Option exercise +10,000 $6.49 $64,900 10,000 D
Derivatives
Crystal Adam Chief Medical Officer 2021-10-08 Option exercise · Stock Option (Right to Buy) −10,000 132,292 D
Loading xslF345X03/doc4.xml…